Gilead Sciences (NASDAQ:GILD) executives highlighted what they described as a “remarkable year” of clinical, commercial, and ...
Danaos Corp (DAC) reports strong liquidity and revenue growth, despite challenges from increased operating and interest expenses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results